Sorry, you do not have access to this eBook
A subscription is required to access the full text content of this book.
As the medical research industry progresses, the methods of researching the effects of drugs on the lungs have moved to models and simulations. This chapter aims to answer the question, “To what extent has modeling and simulation of biopharmaceutical performance helped improve lung drug delivery?” It focuses on topics such as applications of modeling and simulation of biopharmaceutical performance, what modeling and simulations are helpful for, and the current use and implications of future use.
A subscription is required to access the full text content of this book.
Other ways to access this content: